Market Analysis 

The Percutaneous Coronary Intervention Market Outlook and Analysis by Product Type (Coronary Stents, PTCA Catheters, Coronary Guidewire and Accessories), by End User (Hospitals & Specialty Clinics, Ambulatory Surgical Centers, Research and Academic Institutes and others) and by Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2030

The global percutaneous coronary intervention market is predicted to touch USD 15,205.4 million at a 5.1% CAGR over the forecast period, in accordance with the latest Market Research Future (MRFR) report. Formerly referred as angioplasty with stent, percutaneous coronary intervention or PCI is a non-surgical technique which utilizes a catheter (thin flexible tube) for placing a small structure known as a stent for opening up blood vessels in the heart which has been narrowed due to buildup of plaque, a condition referred to as atherosclerosis. 

Percutaneous coronary intervention helps in improving blood flow, thereby reducing angina (chest pain that is heart-related), making a patient feel better along with increasing their ability to be active. Generally, this procedure is scheduled much ahead of time. PCI can also be used for alleviating congestive heart failure, preventing heart attacks, and above all allowing some patients in avoiding surgical treatment (CABG- coronary artery bypass graft) which includes extensive surgery followed by long rehabilitation time often. 

Various factors are propelling the percutaneous coronary intervention market share growth. These factors, as stated by the latest MRFR report, include rising incidences of various cardiac diseases, growing preference for procedures that are minimally invasive, and growing geriatric population who are more susceptible to cardiac diseases. 

On the contrary, strict government regulations and risk of infection are factors that may hamper the percutaneous coronary intervention market share growth over the forecast period. 

Market Segmentation

The MRFR report provides a complete segmental analysis of the percutaneous coronary intervention market share report based on end user as well as product type. 

Based on product type, the percutaneous coronary intervention market share is segmented into accessories, coronary guidewire, PTCA catheters, and coronary stents. Of these, the coronary stents segment will have the largest share in the market over the forecast period. This is chiefly due to the introduction of new products in this market. 

Based on end user, the percutaneous coronary intervention market is segmented into research & academic institutes, ambulatory surgical centers, hospitals and specialty clinics, and others. Of these, the hospitals and specialty clinics segment will dominate the market over the forecast period. This is due to the higher availability of experts required for performing the procedure coupled with a higher footfall of patients in hospitals.

Regional Analysis

By region, the percutaneous coronary intervention market share report covers the latest trends and growth opportunities across Europe, the Asia Pacific (APAC), the Americas, and the Middle East and Africa (MEA). Of these, the Americas is expected to dominate the market during the forecast period due to the increasing acceptability of percutaneous coronary intervention methods and growing awareness. 

Europe is projected to have the second-largest share in the market during the forecast period. This is owing to the growing number of hospitalizations for percutaneous coronary intervention methods such as cerebral angioplasty and carotid artery angioplasty. 

Key Players

Leading players profiled in the percutaneous coronary intervention market report include Terumo Corporation (Japan), Merit Medical System (Utah), Meril Lifesciences Pvt. Ltd (India), Medtronic PLC (US), Cordis (US), Cook (US), Comed BV (Netherlands), C. R. Bard, Inc. (US), Boston Scientific Corporation (US), BIOTRONIK (US), Biosensors International Group, Ltd (Singapore), B. Braun Melsungen AG (UK), ASAHI INTECC Company Limited (Japan), and Abbott (US), among others. Key players are adopting different strategies to create a niche in the market, such as research and development, joint ventures, mergers and acquisitions, partnerships, product innovations and launches, collaborations, and more. 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com